Cleveland Clinic Genetics Expert Continues Research with Ex-OSU Colleagues; Team gets $11 million grant
Plain Dealer - Sept 9, 2013
Dr. Charis Eng, chairwoman and founder of the Cleveland Clinic's Genomic Medicine Institute, is leading up a portion of thyroid cancer research that is getting $11.3 million over five years.
Valerie Harper's Cancer Comeback: From Terminal Diagnosis to 'Dancing with the Stars'
Fox News - Sept 4, 2013
Despite a diagnosis of terminal cancer, actress Valerie Harper is now engaged in four-hour-a-day dance rehearsals in preparation for "Dancing with the Stars," according to People magazine. Though Harper's comeback is rare, Dr. Lisa Rachel Rogers, medical director of the neuro-oncology program at University Hospital's Case Medical Center in Cleveland, said it's not entirely unheard of for patients with Harper's disease.
Early Intervention Prolonged Time to Progression in Smoldering Myeloma
Helio/HemOnc Today - Aug 14, 2013
Dr. Frederic Reu discusses results from smoldering multiple myeloma clinical trial.
Clinical and Translational Science Collaborative Annual Pilot Awards
Congratulations to the six faculty members and researchers who were awarded the 2013 Clinical & Translational Science Collaborative's annual pilot awards.
Database of Potential Student Lab Assistants
The Cancer Center has a database of undergraduate and graduate students who are interested in working in cancer research labs or are doing rotations for the Biomedical Sciences Training Program (BSTP). If you are interested in hosting a student volunteer, employee, or rotation, please contact Lyn Haselton at firstname.lastname@example.org. We appreciate your support and interest in training the next generation of cancer researchers!
PET/MR Workshop: What You Need to Know
The Department of Radiology is hosting PET/MR Workshop: What You Need to Know on September 13 from 8-5 pm in BRB 105. This symposium brings together some of the pioneers in the novel field of PET-MR Imaging using a practical approach to share the initial clinical experience of this new modality combining the expertise of MR and nuclear medicine images. The target audience for this CME event includes radiologists, nuclear medicine physicians, oncologists, cardiovascular and neurological specialists, primary care physicians and technologists.
MetroHealth Research Symposium
The annual MetroHealth Research Symposium will be held Wednesday, September 18 from 8 am - 6 pm. Activities include poster displays, an oral presentation competition, a poster presentation competition and a keynote address.
The Keynote Speaker, Tony Wynshaw-Boris, MD, PhD, is Chair of Genetics and Genome Sciences at CWRU. He will present his talk, Neurogenetic diseases: From pathogenesis to therapeutics at 5 pm in Rammelkamp 170.
This entire symposium is open to everyone in the community, and would be of particular interest to students, fellows, and scientific and medical professionals. No registration is required. Contact Cindy Pollak at email@example.com or 216-778-8718 for more information.
Point of Care Technologies for Cancer
The National Institutes of Health is hosting a conference on Cancer Technologies, October 7-9, on the NIH campus in Bethesda, Maryland. The conference, Point of Care Technologies for Cancer, is co-sponsored by National Cancer Institute and the National Institute of Biomedical Imaging and Bioengineering. The main goal of the conference is to facilitate new scientific collaborations and interactions among cancer researchers and bioengineers, and to build new research programs in this important field in order to promote the translation of new technologies into clinical applications.
In addition to the main conference on October 8-9, there will be a pre-conference symposium on October 7 on Cancer Detection, Diagnostics and Treatment Technologies for Global Health sponsored by the NCI Center for Global Health. The pre-conference will be especially relevant for those interested in global health, since it will focus on the development of cancer-relevant technologies suitable for environments with limited resources. NCI is also targeting this topic area through a new global health funding initiative.
Although there is no registration fee, there are limited seats and all attendees are required to register.
American Skin Association
The American Skin Association is accepting applications for the following funding opportunities. Please note that a Chair can endorse only one Scholar Award (either category) and one research grant each year.
Limited Submission: NSF Major Research Instrumentation Program
The Major Research Instrumentation Program (MRI) seeks to improve the quality and expand the scope of research and research training in science and engineering, by supporting proposals for shared instrumentation that fosters the integration of research and education in research-intensive learning environments. Each MRI proposal may request support for the acquisition (Track 1) or development (Track 2) of a single research instrument for shared inter- and/or intra-organizational use; development efforts that leverage the strengths of private sector partners to build instrument development capacity at MRI submission-eligible organizations are encouraged.
To accomplish the program's goals, the MRI program assists with the acquisition or development of a shared research instrument that is, in general, too costly and/or not appropriate for support through other NSF programs. The instrument is expected to be operational for regular research use by the end of the award period.
Internal Deadline: October 14
External Deadline: January 23, 2014
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Pezcoller Foundation–AACR International Award for Cancer Research
AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research
Case CCC Protocol Specific Research Support (PSRS)
International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.
Biomedical Engineering Visiting Lecturer
Marie Kveiborg, PhD
Associate Professor, Biomedical Sciences & BRIC
University of Copenhagen
Topic: ADAM Proteases in Cancer - The Importance of Intracellular Protein Trafficking
11 am NE1-205 Cleveland Clinic
Pathology Research Seminar Series
Mark W. Jackson, PhD
Assistant Professor, Pathology
Topic: Identifying Novel Regulators of Oncogenic Signaling
12 pm WRB 1-413
Frank Jacono, MD
Assistant Professor, Pulmonary, Critical Care and Sleep Medicine
Topic: Ventilatory Pattern Variability Following Acute Lung Injury: Insights into Central Mechanisms and Clinical Implications
4 pm SOM / Robbins Building, E-501
Cancer Biology Staff Candidate Seminar
Selina Chen-Kiang, PhD
Professor, Pathology & Laboratory Medicine and Microbiology & Immunology
Weill Cornell Medical College
Topic: Reprogramming Cancer Cells for Cytotoxic Killing by Targeting CDK4/CDK6: Mechanism and Therapy
11 am NC1-202 Cleveland Clinic
Immunology Seminar Series
Pushpa Pandiyan, PhD
Assistant Professor, Biological Sciences
Topic: The Role of IL-15 in Regulating Th17 Cells
12 pm WRB 1-413
Hematology and Oncology Research Conference Special Presentation
David E. Avigan, MD
Associate Professor, Medicine
Harvard Medical School
Topic: Challenges in Vaccine Therapy
8 am Lerner B-151
Breast Program Seminar
William Schiemann, PhD
Associate Professor, General Medical Sciences-Oncology
Topic: TGFβ and Breast Cancer Metastasis
Joseph Baar, MD
Associate Professor, Div. of Hem/Onc
Topic: Overcoming Stromal-Specific Immune Escape Mechanisms by Targeted Immunotherapy
5:30 pm Robbins E301; Cleveland Clinic R3-002 (Teleconference)
Ohio Clinical Trials Collaborative Town Hall
5:30 pm WRB 1-413
Immunology Journal Club
PhD Student, Lederman lab, Pathology
Topic: Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella Pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine
12 pm WRB 5-136
Molecular Biology and Microbiology
Markus Thali, PhD
Professor, Microbiology and Molecular Genetics
University of Vermont
Topic: Fusion Control at the Virological Synapse
1 pm Rottman Seminar Room W203
Hematology/Oncology Fellows Conference/Curriculum Series
Beth Mclaughlin, MD
Polly Mazanec, PhD, CNP
Helen Foley, MSN, AOCNS
Topic: The Science and Art of Pain Management
8 am Wearn 137/Breen Conference Rm
Taussig Cancer Institute Grand Rounds
Joshua Lukenbill, MD
Topic: The Evolution of Therapy for Acute Myeloid Leukemia
8 am R3/002-003 Cleveland Clinic
New Directions in Melanoma and Non-Melanoma Skin Cancers
Holiday Inn–Cleveland South
National GvHD Health Symposium
Embassy Suites Cleveland-Rockside